LONG COVID-19
Clinical trials for LONG COVID-19 explained in plain language.
Never miss a new study
Get alerted when new LONG COVID-19 trials appear
Sign up with your email to follow new studies for LONG COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Low-Dose immune drug ease long COVID symptoms?
Disease control Recruiting nowThis study tests whether a low dose of sirolimus (rapamycin), a drug that calms the immune system, can help adults with Long COVID feel better. Eighty participants will take either sirolimus or a placebo pill once a week for 12 weeks. The main goal is to see if the drug improves …
Matched conditions: LONG COVID-19
Phase: PHASE3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug anktiva tested for long COVID relief
Disease control Recruiting nowThis study tests the safety of a drug called Anktiva in 40 adults with Long COVID—persistent symptoms after a COVID-19 infection. Participants receive the drug as a shot, and researchers monitor for side effects and changes in symptoms. The goal is to see if Anktiva is safe enoug…
Matched conditions: LONG COVID-19
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC